PeptiDream Inc (PPTDF)
17.00
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
PeptiDream Enterprise Value: 2.175B for Nov. 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 2.175B |
| November 13, 2024 | 2.175B |
| November 12, 2024 | 2.175B |
| November 11, 2024 | 2.175B |
| November 08, 2024 | 2.175B |
| November 07, 2024 | 2.175B |
| November 06, 2024 | 2.175B |
| November 05, 2024 | 2.175B |
| November 04, 2024 | 2.175B |
| November 01, 2024 | 2.175B |
| October 31, 2024 | 2.175B |
| October 30, 2024 | 2.175B |
| October 29, 2024 | 2.175B |
| October 28, 2024 | 2.175B |
| October 25, 2024 | 2.175B |
| October 24, 2024 | 2.175B |
| October 23, 2024 | 2.175B |
| October 22, 2024 | 2.175B |
| October 21, 2024 | 2.175B |
| October 18, 2024 | 2.175B |
| October 17, 2024 | 2.175B |
| October 16, 2024 | 2.175B |
| October 15, 2024 | 2.175B |
| October 14, 2024 | 2.175B |
| October 11, 2024 | 2.175B |
| Date | Value |
|---|---|
| October 10, 2024 | 2.175B |
| October 09, 2024 | 2.175B |
| October 08, 2024 | 2.175B |
| October 07, 2024 | 2.175B |
| October 04, 2024 | 2.175B |
| October 03, 2024 | 2.175B |
| October 02, 2024 | 2.175B |
| October 01, 2024 | 2.175B |
| September 30, 2024 | 2.175B |
| September 27, 2024 | 2.175B |
| September 26, 2024 | 2.175B |
| September 25, 2024 | 2.175B |
| September 24, 2024 | 2.175B |
| September 23, 2024 | 2.175B |
| September 20, 2024 | 2.175B |
| September 19, 2024 | 2.175B |
| September 18, 2024 | 2.175B |
| September 17, 2024 | 2.175B |
| September 16, 2024 | 2.175B |
| September 13, 2024 | 2.175B |
| September 12, 2024 | 2.175B |
| September 11, 2024 | 2.175B |
| September 10, 2024 | 2.175B |
| September 09, 2024 | 2.175B |
| September 06, 2024 | 2.175B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
996.42M
Minimum
Oct 31 2023
7.515B
Maximum
Feb 11 2021
3.077B
Average
2.170B
Median
Apr 26 2022
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 72.05B |
| Nxera Pharma Co Ltd | 818.86M |
| Healios KK | 117.61M |
| AnGes Inc | 86.92M |
| SanBio Co Ltd | 247.52M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 120.39M |
| Revenue (Quarterly) | 204.69M |
| Total Expenses (Quarterly) | 39.52M |
| EPS Diluted (Quarterly) | 0.9276 |
| Gross Profit Margin (Quarterly) | 89.26% |
| Profit Margin (Quarterly) | 58.82% |
| Earnings Yield | 6.38% |
| Operating Earnings Yield | 9.59% |
| Normalized Earnings Yield | 6.384 |